{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T09:10:49Z","timestamp":1778922649914,"version":"3.51.4"},"reference-count":116,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T00:00:00Z","timestamp":1641254400000},"content-version":"vor","delay-in-days":3,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006447","name":"Universit\u00e4t Z\u00fcrich","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006447","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"publisher","award":["31CA30_196177\/1"],"award-info":[{"award-number":["31CA30_196177\/1"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Research in Virological Science"],"published-print":{"date-parts":[[2022]]},"DOI":"10.1016\/j.crviro.2022.100019","type":"journal-article","created":{"date-parts":[[2022,1,15]],"date-time":"2022-01-15T11:46:26Z","timestamp":1642247186000},"page":"100019","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Identification of broad anti-coronavirus chemical agents for repurposing against SARS-CoV-2 and variants of concern"],"prefix":"10.1016","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2137-4576","authenticated-orcid":false,"given":"Luca","family":"Murer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4442-4652","authenticated-orcid":false,"given":"Romain","family":"Volle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9619-6655","authenticated-orcid":false,"given":"Vardan","family":"Andriasyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4135-9576","authenticated-orcid":false,"given":"Anthony","family":"Petkidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1478-3563","authenticated-orcid":false,"given":"Alfonso","family":"Gomez-Gonzalez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liliane","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Meili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3276-3008","authenticated-orcid":false,"given":"Maarit","family":"Suomalainen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8156-4603","authenticated-orcid":false,"given":"Michael","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Policarpo Sequeira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5389-4034","authenticated-orcid":false,"given":"Dominik","family":"Olszewski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4803-5099","authenticated-orcid":false,"given":"Fanny","family":"Georgi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2575-1989","authenticated-orcid":false,"given":"Fabien","family":"Kuttler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0139-223X","authenticated-orcid":false,"given":"Gerardo","family":"Turcatti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2278-120X","authenticated-orcid":false,"given":"Urs F.","family":"Greber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.crviro.2022.100019_bib1","doi-asserted-by":"crossref","first-page":"e00221","DOI":"10.1128\/mBio.00221-18","article-title":"Coronavirus susceptibility to the antiviral remdesivir (GS-5734) is mediated by the viral polymerase and the proofreading exoribonuclease","volume":"9","author":"Agostini","year":"2018","journal-title":"mBio"},{"issue":"8","key":"10.1016\/j.crviro.2022.100019_bib2","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrd1468","article-title":"Drug repositioning: identifying and developing new uses for existing drugs","volume":"3","author":"Ashburn","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"issue":"4","key":"10.1016\/j.crviro.2022.100019_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0125028","article-title":"Activating the Wnt\/\u03b2-catenin pathway for the treatment of melanoma\u2013application of LY2090314, a novel selective inhibitor of glycogen synthase kinase-3","volume":"10","author":"Atkinson","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.crviro.2022.100019_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41420-020-0237-8","article-title":"Preclinical studies reveal MLN4924 is a promising new retinoblastoma therapy","volume":"6","author":"Aubry","year":"2020","journal-title":"Cell Death Discov."},{"issue":"6","key":"10.1016\/j.crviro.2022.100019_bib5","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.3390\/cells9061427","article-title":"The role of GSK-3 in cancer immunotherapy: GSK-3 inhibitors as a new frontier in cancer treatment","volume":"9","author":"Augello","year":"2020","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.crviro.2022.100019_bib6","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"1","key":"10.1016\/j.crviro.2022.100019_bib7","doi-asserted-by":"crossref","first-page":"3309","DOI":"10.1038\/s41467-021-23328-0","article-title":"Drug repurposing screens identify chemical entities for the development of COVID-19 interventions","volume":"12","author":"Bakowski","year":"2021","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.crviro.2022.100019_bib8","first-page":"e435","article-title":"Occurrence of SARS-CoV-2 during mycophenolate mofetil treatment for pemphigus","volume":"34","author":"Balestri","year":"2020","journal-title":"J.\u00a0Eur. Acad. Dermatol. Venereol."},{"issue":"5","key":"10.1016\/j.crviro.2022.100019_bib9","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.cell.2020.10.004","article-title":"SARS-CoV-2 disrupts splicing, translation, and protein trafficking to suppress host defenses","volume":"183","author":"Banerjee","year":"2020","journal-title":"Cell"},{"issue":"19","key":"10.1016\/j.crviro.2022.100019_bib10","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMoa2007764","article-title":"Remdesivir for the treatment of Covid-19 - final report","volume":"383","author":"Beigel","year":"2020","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"19","key":"10.1016\/j.crviro.2022.100019_bib11","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMoa2007764","article-title":"Remdesivir for the treatment of Covid-19","volume":"383","author":"Beigel","year":"2020","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"1","key":"10.1016\/j.crviro.2022.100019_bib12","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1128\/JVI.05937-11","article-title":"Complex dynamic development of poliovirus membranous replication complexes","volume":"86","author":"Belov","year":"2012","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.crviro.2022.100019_bib13","doi-asserted-by":"crossref","first-page":"600372","DOI":"10.3389\/fphar.2020.600372","article-title":"Methylene blue inhibits the SARS-CoV-2 spike-ACE2 protein-protein interaction-a mechanism that can contribute to its antiviral activity against COVID-19","volume":"11","author":"Bojadzic","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.crviro.2022.100019_bib14","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1128\/AAC.00773-07","article-title":"Interactions of methylene blue with human disulfide reductases and their orthologues from Plasmodium falciparum","volume":"52","author":"Buchholz","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"issue":"3","key":"10.1016\/j.crviro.2022.100019_bib15","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1124\/mol.65.3.744","article-title":"SB-505124 is a selective inhibitor of transforming growth factor-\u03b2 type I receptors ALK4, ALK5, and ALK7","volume":"65","author":"Byfield","year":"2004","journal-title":"Mol. Pharmacol."},{"issue":"10","key":"10.1016\/j.crviro.2022.100019_bib16","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/s41577-020-00421-x","article-title":"After 62 years of regulating immunity, dexamethasone meets COVID-19","volume":"20","author":"Cain","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"6518","key":"10.1016\/j.crviro.2022.100019_bib17","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1126\/science.abd2985","article-title":"Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity","volume":"370","author":"Cantuti-Castelvetri","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.crviro.2022.100019_bib18","series-title":"Features, Evaluation, and Treatment of Coronavirus (COVID-19). StatPearls","author":"Cascella","year":"2021"},{"issue":"4","key":"10.1016\/j.crviro.2022.100019_bib19","doi-asserted-by":"crossref","first-page":"e00171","DOI":"10.1128\/mBio.00171-10","article-title":"Dendritic cell-specific antigen delivery by coronavirus vaccine vectors induces long-lasting protective antiviral and antitumor immunity","volume":"1","author":"Cervantes-Barragan","year":"2010","journal-title":"mBio"},{"issue":"13","key":"10.1016\/j.crviro.2022.100019_bib20","doi-asserted-by":"crossref","first-page":"10236","DOI":"10.1074\/jbc.M111.321133","article-title":"Inhibitors of V-ATPase proton transport reveal uncoupling functions of tether linking cytosolic and membrane domains of V0 subunit a (Vph1p)","volume":"287","author":"Chan","year":"2012","journal-title":"J.\u00a0Biol. Chem."},{"issue":"9","key":"10.1016\/j.crviro.2022.100019_bib21","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1073\/pnas.0808790106","article-title":"Functional screen reveals SARS coronavirus nonstructural protein nsp14 as a novel cap N7 methyltransferase","volume":"106","author":"Chen","year":"2009","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.crviro.2022.100019_bib22","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cytogfr.2020.05.003","article-title":"The cytokine storm in COVID-19: an overview of the involvement of the chemokine\/chemokine-receptor system","volume":"53","author":"Coperchini","year":"2020","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.crviro.2022.100019_bib23","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/bs.aivir.2018.01.001","article-title":"Hosts and sources of endemic human coronaviruses","volume":"100","author":"Corman","year":"2018","journal-title":"Adv. Virus Res."},{"issue":"4","key":"10.1016\/j.crviro.2022.100019_bib24","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/nm.4306","article-title":"The Drug Repurposing Hub: a next-generation drug library and information resource","volume":"23","author":"Corsello","year":"2017","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.crviro.2022.100019_bib25","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41564-020-00835-2","article-title":"Therapeutically administered ribonucleoside analogue MK-4482\/EIDD-2801 blocks SARS-CoV-2 transmission in ferrets","volume":"6","author":"Cox","year":"2021","journal-title":"Nat. Microbiol."},{"issue":"13","key":"10.1016\/j.crviro.2022.100019_bib26","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1001\/jama.2021.3199","article-title":"SARS-CoV-2 vaccines","volume":"325","author":"Creech","year":"2021","journal-title":"JAMA"},{"issue":"6518","key":"10.1016\/j.crviro.2022.100019_bib27","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1126\/science.abd3072","article-title":"Neuropilin-1 is a host factor for SARS-CoV-2 infection","volume":"370","author":"Daly","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.crviro.2022.100019_bib28","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.antiviral.2018.03.003","article-title":"Favipiravir as a potential countermeasure against neglected and emerging RNA viruses","volume":"153","author":"Delang","year":"2018","journal-title":"Antivir. Res."},{"issue":"7","key":"10.1016\/j.crviro.2022.100019_bib29","first-page":"e295","article-title":"Should SARS-CoV-2 influence immunosuppressive therapy for autoimmune blistering diseases?","volume":"34","author":"Di Altobrando","year":"2020","journal-title":"J.\u00a0Eur. Acad. Dermatol. Venereol."},{"issue":"1","key":"10.1016\/j.crviro.2022.100019_bib30","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1038\/s41467-021-21992-w","article-title":"Favipiravir antiviral efficacy against SARS-CoV-2 in a hamster model","volume":"12","author":"Driouich","year":"2021","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.crviro.2022.100019_bib31","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3390\/ph13080196","article-title":"Avermectin derivatives, pharmacokinetics, therapeutic and toxic dosages, mechanism of action, and their biological effects","volume":"13","author":"El-Saber Batiha","year":"2020","journal-title":"Pharmaceuticals"},{"issue":"2","key":"10.1016\/j.crviro.2022.100019_bib32","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1365-3083.1991.tb03747.x","article-title":"Lymphocyte-selective antiproliferative and immunosuppressive effects of mycophenolic acid in mice","volume":"33","author":"Eugui","year":"1991","journal-title":"Scand. J. Immunol."},{"issue":"6","key":"10.1016\/j.crviro.2022.100019_bib33","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1128\/AAC.01295-10","article-title":"The HIV protease inhibitor nelfinavir inhibits Kaposi's sarcoma-associated herpesvirus replication in vitro","volume":"55","author":"Gantt","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"issue":"6","key":"10.1016\/j.crviro.2022.100019_bib34","doi-asserted-by":"crossref","first-page":"106202","DOI":"10.1016\/j.ijantimicag.2020.106202","article-title":"Methylene blue inhibits replication of SARS-CoV-2 in vitro","volume":"56","author":"Gendrot","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"9","key":"10.1016\/j.crviro.2022.100019_bib35","doi-asserted-by":"crossref","first-page":"e01002","DOI":"10.1128\/AAC.01002-20","article-title":"The FDA-approved drug Nelfinavir inhibits lytic cell-free, but not cell-associated non-lytic transmission of human adenovirus","volume":"64","author":"Georgi","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.crviro.2022.100019_bib119","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41597-020-00604-0","article-title":"A\u00a0high-content image-based drug screen of clinical compounds against cell transmission of adenovirus","volume":"7","author":"Georgi","year":"2020","journal-title":"Sci. Data"},{"issue":"4","key":"10.1016\/j.crviro.2022.100019_bib38","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02479-20","article-title":"AT-527, a double prodrug of a guanosine nucleotide analog, is a potent inhibitor of SARS-CoV-2 in vitro and a promising oral antiviral for treatment of COVID-19","volume":"65","author":"Good","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.crviro.2022.100019_bib39","doi-asserted-by":"crossref","DOI":"10.1002\/1873-3468.14226","article-title":"Two years into COVID-19 \u2013 lessons in SARS-CoV-2 and a perspective from papers in FEBS Letters","author":"Greber","year":"2021","journal-title":"FEBS (Fed. Eur. Biochem. Soc.) Lett."},{"issue":"23","key":"10.1016\/j.crviro.2022.100019_bib40","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1056\/NEJMoa2105000","article-title":"Vaccine breakthrough infections with SARS-CoV-2 variants","volume":"384","author":"Hacisuleyman","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"3","key":"10.1016\/j.crviro.2022.100019_bib41","first-page":"190","article-title":"Methylene blue for treatment of hospitalized Covid-19 patients: a randomized, controlled, open-label clinical trial, phase 2","volume":"73","author":"Hamidi-Alamdari","year":"2021","journal-title":"Rev. Invest. Clin."},{"issue":"7841","key":"10.1016\/j.crviro.2022.100019_bib42","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2901-9","article-title":"Identification of SARS-CoV-2 inhibitors using lung and colonic organoids","volume":"589","author":"Han","year":"2021","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.crviro.2022.100019_bib43","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1128\/AAC.40.10.2237","article-title":"In vitro and in vivo antifungal activities of ER-30346, a novel oral triazole with a broad antifungal spectrum","volume":"40","author":"Hata","year":"1996","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.crviro.2022.100019_bib44","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1177\/0091270010390807","article-title":"Use of an adaptive study design in single ascending-dose pharmacokinetics of A0001 (\u03b1-Tocopherylquinone) in healthy male subjects","volume":"52","author":"Hawi","year":"2012","journal-title":"J.\u00a0Clin. Pharmacol."},{"issue":"7","key":"10.1016\/j.crviro.2022.100019_bib45","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1021\/cr900021w","article-title":"IMP dehydrogenase: structure, mechanism, and inhibition","volume":"109","author":"Hedstrom","year":"2009","journal-title":"Chem. Rev."},{"key":"10.1016\/j.crviro.2022.100019_bib46","unstructured":"Home. COVID-19 Map - Johns Hopkins Coronavirus Resource Center."},{"issue":"10223","key":"10.1016\/j.crviro.2022.100019_bib47","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.crviro.2022.100019_bib48","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1073\/pnas.1809667116","article-title":"Human coronaviruses OC43 and HKU1 bind to 9-O-acetylated sialic acids via a conserved receptor-binding site in spike protein domain A","volume":"116","author":"Hulswit","year":"2019","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"issue":"2","key":"10.1016\/j.crviro.2022.100019_bib49","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.tibs.2003.12.004","article-title":"The glamour and gloom of glycogen synthase kinase-3","volume":"29","author":"Jope","year":"2004","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.crviro.2022.100019_bib50","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ijid.2020.10.069","article-title":"Role of favipiravir in the treatment of COVID-19","volume":"102","author":"Joshi","year":"2021","journal-title":"Int. J. Infect. Dis."},{"issue":"10","key":"10.1016\/j.crviro.2022.100019_bib51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002976","article-title":"Niclosamide is a proton carrier and targets acidic endosomes with broad antiviral effects","volume":"8","author":"Jurgeit","year":"2012","journal-title":"PLoS Pathog."},{"issue":"5","key":"10.1016\/j.crviro.2022.100019_bib52","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1517\/14728222.11.5.695","article-title":"Nicotinamide adenine dinucleotide metabolism as an attractive target for drug discovery","volume":"11","author":"Khan","year":"2007","journal-title":"Expert Opin. Ther. Targets"},{"issue":"4","key":"10.1016\/j.crviro.2022.100019_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2020.04.011","article-title":"The architecture of SARS-CoV-2 transcriptome","volume":"181","author":"Kim","year":"2020","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.crviro.2022.100019_bib54","doi-asserted-by":"crossref","first-page":"100137","DOI":"10.1016\/j.xcrm.2020.100137","article-title":"A\u00a0high-content screen for mucin-1-reducing compounds identifies fostamatinib as a candidate for rapid repurposing for acute lung injury","volume":"1","author":"Kost-Alimova","year":"2020","journal-title":"Cell Rep. Med."},{"issue":"4","key":"10.1016\/j.crviro.2022.100019_bib55","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.cell.2020.06.044","article-title":"Longitudinal isolation of potent near-germline SARS-CoV-2-neutralizing antibodies from COVID-19 patients","volume":"182","author":"Kreer","year":"2020","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.crviro.2022.100019_bib56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep24218","article-title":"Neddylation inhibitor MLN4924 suppresses growth and migration of human gastric cancer cells","volume":"6","author":"Lan","year":"2016","journal-title":"Sci. Rep."},{"issue":"16","key":"10.1016\/j.crviro.2022.100019_bib57","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.2174\/156802611796575902","article-title":"Sterol 14alpha-demethylase (CYP51) as a therapeutic target for human trypanosomiasis and leishmaniasis","volume":"11","author":"Lepesheva","year":"2011","journal-title":"Curr. Top. Med. Chem."},{"issue":"2","key":"10.1016\/j.crviro.2022.100019_bib58","article-title":"Rapid biochemical test for measuring chemical toxicity","volume":"26","author":"Liu","year":"1981","journal-title":"Bull. Environ. Contam. Toxicol."},{"issue":"42","key":"10.1016\/j.crviro.2022.100019_bib59","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2113401118","article-title":"Targeting the coronavirus nucleocapsid protein through GSK-3 inhibition","volume":"118","author":"Liu","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"43","key":"10.1016\/j.crviro.2022.100019_bib60","doi-asserted-by":"crossref","first-page":"26946","DOI":"10.1073\/pnas.2012294117","article-title":"Remdesivir targets a structurally analogous region of the Ebola virus and SARS-CoV-2 polymerases","volume":"117","author":"Lo","year":"2020","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"issue":"1","key":"10.1016\/j.crviro.2022.100019_bib61","doi-asserted-by":"crossref","DOI":"10.1038\/srep35100","article-title":"Translation elongation factor eEF1A2 is a novel anticancer target for the marine natural product plitidepsin","volume":"6","author":"Losada","year":"2016","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.crviro.2022.100019_bib62","doi-asserted-by":"crossref","first-page":"26654","DOI":"10.3390\/ijms161125985","article-title":"Mycophenolate mofetil modulates differentiation of Th1\/Th2 and the secretion of cytokines in an active Crohn's disease mouse model","volume":"16","author":"Lv","year":"2015","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.crviro.2022.100019_bib63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep09054","article-title":"The cholesterol biosynthesis enzyme oxidosqualene cyclase is a new target to impair tumour angiogenesis and metastasis dissemination","volume":"5","author":"Maione","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.crviro.2022.100019_bib64","doi-asserted-by":"crossref","first-page":"9054","DOI":"10.1038\/srep09054","article-title":"The cholesterol biosynthesis enzyme oxidosqualene cyclase is a new target to impair tumour angiogenesis and metastasis dissemination","volume":"5","author":"Maione","year":"2015","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.crviro.2022.100019_bib65","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1128\/AAC.47.2.577-581.2003","article-title":"Mutations in Aspergillus fumigatus resulting in reduced susceptibility to posaconazole appear to be restricted to a single amino acid in the cytochrome P450 14alpha-demethylase","volume":"47","author":"Mann","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"issue":"3","key":"10.1016\/j.crviro.2022.100019_bib66","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.bone.2011.11.007","article-title":"GSK-3 inhibition by an orally active small molecule increases bone mass in rats","volume":"50","author":"Marsell","year":"2012","journal-title":"Bone"},{"issue":"10229","key":"10.1016\/j.crviro.2022.100019_bib67","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.crviro.2022.100019_bib68","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.chembiol.2003.11.010","article-title":"GSK-3-selective inhibitors derived from Tyrian purple indirubins","volume":"10","author":"Meijer","year":"2003","journal-title":"Chem. Biol."},{"issue":"7883","key":"10.1016\/j.crviro.2022.100019_bib69","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/s41586-021-03944-y","article-title":"SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion","volume":"599","author":"Mlcochova","year":"2021","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.crviro.2022.100019_bib70","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0022-2275(20)37449-6","article-title":"Ro 48-8.071, a new 2, 3-oxidosqualene: lanosterol cyclase inhibitor lowering plasma cholesterol in hamsters, squirrel monkeys, and minipigs: comparison to simvastatin","volume":"38","author":"Morand","year":"1997","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.crviro.2022.100019_bib71","first-page":"JVI0106021","article-title":"Chemical evolution of Rhinovirus identifies capsid-destabilizing mutations driving low pH-independent genome uncoating","author":"Murer","year":"2021","journal-title":"J.\u00a0Virol."},{"issue":"10","key":"10.1016\/j.crviro.2022.100019_bib72","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/s41575-021-00480-y","article-title":"COVID-19: biologic and immunosuppressive therapy in gastroenterology and hepatology","volume":"18","author":"Neurath","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"7","key":"10.1016\/j.crviro.2022.100019_bib73","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.14741","article-title":"Association of remdesivir treatment with survival and length of hospital stay among US Veterans hospitalized with COVID-19","volume":"4","author":"Ohl","year":"2021","journal-title":"JAMA Netw. Open"},{"issue":"1","key":"10.1016\/j.crviro.2022.100019_bib74","first-page":"1","article-title":"SARS-CoV2-mediated suppression of NRF2-signaling reveals potent antiviral and anti-inflammatory activity of 4-octyl-itaconate and dimethyl fumarate","volume":"11","author":"Olagnier","year":"2020","journal-title":"Nat. Commun."},{"issue":"23","key":"10.1016\/j.crviro.2022.100019_bib75","doi-asserted-by":"crossref","first-page":"2001005","DOI":"10.2807\/1560-7917.ES.2020.25.23.2001005","article-title":"SARS-CoV-2 infection in farmed minks, The Netherlands, April and May 2020","volume":"25","author":"Oreshkova","year":"2020","journal-title":"Euro Surveill."},{"issue":"18","key":"10.1016\/j.crviro.2022.100019_bib76","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1002\/1873-3468.14182","article-title":"Interface-based design of the favipiravir-binding site in SARS-CoV-2 RNA-dependent RNA polymerase reveals mutations conferring resistance to chain termination","volume":"595","author":"Padhi","year":"2021","journal-title":"FEBS Lett."},{"issue":"1","key":"10.1016\/j.crviro.2022.100019_bib77","first-page":"18","article-title":"The emergence of mycophenolate mofetilin dermatology: from its roots in the world of organ transplantation to its versatile role in the dermatology treatment room","volume":"4","author":"Park","year":"2011","journal-title":"J.\u00a0Clin. Aesthetic Dermatol."},{"issue":"4","key":"10.1016\/j.crviro.2022.100019_bib78","doi-asserted-by":"crossref","first-page":"253","DOI":"10.4103\/0972-5229.130582","article-title":"Methylene blue unresponsive methemoglobinemia","volume":"18","author":"Patnaik","year":"2014","journal-title":"Indian J. Crit. Care Med.: peer-reviewed official publication of Indian Society of Critical Care Medicine"},{"issue":"3","key":"10.1016\/j.crviro.2022.100019_bib79","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s002280000124","article-title":"Pharmacokinetics and organ distribution of intravenous and oral methylene blue","volume":"56","author":"Peter","year":"2000","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"7","key":"10.1016\/j.crviro.2022.100019_bib80","first-page":"588","article-title":"Efficacy of cetylpyridinium chloride used as oropharyngeal antiseptic","volume":"51","author":"Pitten","year":"2001","journal-title":"Arzneimittelforschung"},{"issue":"4","key":"10.1016\/j.crviro.2022.100019_bib81","doi-asserted-by":"crossref","first-page":"100059","DOI":"10.1016\/j.xcrm.2020.100059","article-title":"Characterization and treatment of SARS-CoV-2 in nasal and bronchial human airway epithelia","volume":"1","author":"Pizzorno","year":"2020","journal-title":"Cell. Rep. Med."},{"issue":"7871","key":"10.1016\/j.crviro.2022.100019_bib82","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/s41586-021-03777-9","article-title":"Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization","volume":"596","author":"Planas","year":"2021","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.crviro.2022.100019_bib83","article-title":"The endoplasmic reticulum unfolded protein response\u2013homeostasis, cell death and evolution in virus infections","volume":"45","author":"Prasad","year":"2021","journal-title":"FEMS (Fed. Eur. Microbiol. Soc.) Microbiol. Rev."},{"issue":"3","key":"10.1016\/j.crviro.2022.100019_bib84","doi-asserted-by":"crossref","first-page":"588","DOI":"10.2337\/diabetes.52.3.588","article-title":"Selective glycogen synthase kinase 3 inhibitors potentiate insulin activation of glucose transport and utilization in vitro and in vivo","volume":"52","author":"Ring","year":"2003","journal-title":"Diabetes"},{"issue":"7827","key":"10.1016\/j.crviro.2022.100019_bib85","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/s41586-020-2577-1","article-title":"Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing","volume":"586","author":"Riva","year":"2020","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.crviro.2022.100019_bib86","doi-asserted-by":"crossref","first-page":"4354","DOI":"10.1038\/s41467-021-24521-x","article-title":"SARS-CoV-2 infection induces the dedifferentiation of multiciliated cells and impairs mucociliary clearance","volume":"12","author":"Robinot","year":"2021","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.crviro.2022.100019_bib87","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003056","article-title":"Three-dimensional architecture and biogenesis of membrane structures associated with hepatitis C virus replication","volume":"8","author":"Romero-Brey","year":"2012","journal-title":"PLoS Pathog."},{"issue":"5","key":"10.1016\/j.crviro.2022.100019_bib88","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.chom.2014.10.003","article-title":"Rhinovirus uses a phosphatidylinositol 4-phosphate\/cholesterol counter-current for the formation of replication compartments at the ER-Golgi interface","volume":"16","author":"Roulin","year":"2014","journal-title":"Cell Host Microbe"},{"issue":"5","key":"10.1016\/j.crviro.2022.100019_bib89","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1179\/135100003225002899","article-title":"Methylene blue as an antimalarial agent","volume":"8","author":"Schirmer","year":"2003","journal-title":"Redox Rep."},{"issue":"541","key":"10.1016\/j.crviro.2022.100019_bib90","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abb5883","article-title":"An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice","volume":"12","author":"Sheahan","year":"2020","journal-title":"Sci. Transl. Med."},{"issue":"7239","key":"10.1016\/j.crviro.2022.100019_bib91","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/nature07884","article-title":"An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer","volume":"458","author":"Soucy","year":"2009","journal-title":"Nature"},{"issue":"7239","key":"10.1016\/j.crviro.2022.100019_bib92","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/nature07884","article-title":"An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer","volume":"458","author":"Soucy","year":"2009","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.crviro.2022.100019_bib93","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1517\/14656566.4.12.2325","article-title":"Mycophenolate mofetil in solid-organ transplantation","volume":"4","author":"Srinivas","year":"2003","journal-title":"Expet Opin. Pharmacother."},{"issue":"1","key":"10.1016\/j.crviro.2022.100019_bib94","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2165\/00003088-200746010-00002","article-title":"Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients","volume":"46","author":"Staatz","year":"2007","journal-title":"Clin. Pharmacokinet."},{"issue":"8","key":"10.1016\/j.crviro.2022.100019_bib95","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.3390\/v13081568","article-title":"Virus infection variability by single-cell profiling","volume":"13","author":"Suomalainen","year":"2021","journal-title":"Viruses"},{"issue":"5","key":"10.1016\/j.crviro.2022.100019_bib96","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.252544","article-title":"Cell-to-cell and genome-to-genome variability of adenovirus transcription tuned by the cell cycle","volume":"134","author":"Suomalainen","year":"2020","journal-title":"J.\u00a0Cell Sci."},{"issue":"7813","key":"10.1016\/j.crviro.2022.100019_bib97","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/s41586-020-2294-9","article-title":"Rapid reconstruction of SARS-CoV-2 using a synthetic genomics platform","volume":"582","author":"Thao","year":"2020","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.crviro.2022.100019_bib98","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1021\/jm101157q","article-title":"Identification of a potent Janus kinase 3 inhibitor with high selectivity within the Janus kinase family","volume":"54","author":"Thoma","year":"2011","journal-title":"J.\u00a0Med. Chem."},{"issue":"17","key":"10.1016\/j.crviro.2022.100019_bib99","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1089\/ars.2017.7342","article-title":"Transcriptional regulation by Nrf2","volume":"29","author":"Tonelli","year":"2018","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.crviro.2022.100019_bib100","doi-asserted-by":"crossref","first-page":"e453","DOI":"10.7717\/peerj.453","article-title":"scikit-image: image processing in Python","volume":"2","author":"van der Walt","year":"2014","journal-title":"PeerJ"},{"key":"10.1016\/j.crviro.2022.100019_bib101","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.3389\/fphar.2020.561334","article-title":"Anti-SARS-CoV natural products with the potential to inhibit SARS-CoV-2 (COVID-19)","volume":"11","author":"Verma","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"10269","key":"10.1016\/j.crviro.2022.100019_bib102","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0140-6736(20)32661-1","article-title":"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK","volume":"397","author":"Voysey","year":"2021","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.crviro.2022.100019_bib103","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00228-008-0563-x","article-title":"High absolute bioavailability of methylene blue given as an aqueous oral formulation","volume":"65","author":"Walter-Sack","year":"2009","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"11","key":"10.1016\/j.crviro.2022.100019_bib104","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-009333","article-title":"Trends in clinical development timeframes for antiviral drugs launched in the UK, 1981\u20132014: a retrospective observational study","volume":"5","author":"Ward","year":"2015","journal-title":"BMJ Open"},{"issue":"6532","key":"10.1016\/j.crviro.2022.100019_bib105","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1126\/science.abf4058","article-title":"Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A","volume":"371","author":"White","year":"2021","journal-title":"Science"},{"issue":"47","key":"10.1016\/j.crviro.2022.100019_bib106","doi-asserted-by":"crossref","first-page":"19970","DOI":"10.1073\/pnas.0908837106","article-title":"Crystal structure of NL63 respiratory coronavirus receptor-binding domain complexed with its human receptor","volume":"106","author":"Wu","year":"2009","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"issue":"3","key":"10.1016\/j.crviro.2022.100019_bib107","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.chom.2020.02.001","article-title":"Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China","volume":"27","author":"Wu","year":"2020","journal-title":"Cell Host Microbe"},{"issue":"9","key":"10.1016\/j.crviro.2022.100019_bib108","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0138760","article-title":"Plaque2. 0\u2014a high-throughput analysis framework to score virus-cell transmission and clonal cell expansion","volume":"10","author":"Yakimovich","year":"2015","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.crviro.2022.100019_bib109","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0138760","article-title":"Plaque2.0-A high-throughput analysis framework to score virus-cell transmission and clonal cell expansion","volume":"10","author":"Yakimovich","year":"2015","journal-title":"PLoS One"},{"issue":"6485","key":"10.1016\/j.crviro.2022.100019_bib110","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1126\/science.abb2762","article-title":"Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2","volume":"367","author":"Yan","year":"2020","journal-title":"Science"},{"issue":"6377","key":"10.1016\/j.crviro.2022.100019_bib111","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/357420a0","article-title":"Human aminopeptidase N is a receptor for human coronavirus 229E","volume":"357","author":"Yeager","year":"1992","journal-title":"Nature"},{"issue":"6498","key":"10.1016\/j.crviro.2022.100019_bib112","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1126\/science.abc1560","article-title":"Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir","volume":"368","author":"Yin","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.crviro.2022.100019_bib113","series-title":"A\u00a0Duality Based Approach for Realtime TV-L1 Optical Flow","year":"2007"},{"issue":"2","key":"10.1016\/j.crviro.2022.100019_bib114","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/108705719900400206","article-title":"A\u00a0simple statistical parameter for use in evaluation and validation of high throughput screening assays","volume":"4","author":"Zhang","year":"1999","journal-title":"J.\u00a0Biomol. Screen"},{"issue":"41","key":"10.1016\/j.crviro.2022.100019_bib115","doi-asserted-by":"crossref","first-page":"5520","DOI":"10.1038\/s41388-018-0333-x","article-title":"Inhibition of maternal embryonic leucine zipper kinase with OTSSP167 displays potent anti-leukemic effects in chronic lymphocytic leukemia","volume":"37","author":"Zhang","year":"2018","journal-title":"Oncogene"},{"issue":"17","key":"10.1016\/j.crviro.2022.100019_bib116","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1089\/ars.2013.5795","article-title":"Targeting Neddylation pathways to inactivate cullin-RING ligases for anticancer therapy","volume":"21","author":"Zhao","year":"2014","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.crviro.2022.100019_bib117","article-title":"SynergyFinder Plus: towards a better interpretation and annotation of drug combination screening datasets","author":"Zheng","year":"2021","journal-title":"bioRxiv"}],"container-title":["Current Research in Virological Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666478X22000010?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666478X22000010?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T08:32:45Z","timestamp":1778920365000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666478X22000010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":116,"alternative-id":["S2666478X22000010"],"URL":"https:\/\/doi.org\/10.1016\/j.crviro.2022.100019","relation":{},"ISSN":["2666-478X"],"issn-type":[{"value":"2666-478X","type":"print"}],"subject":[],"published":{"date-parts":[[2022]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of broad anti-coronavirus chemical agents for repurposing against SARS-CoV-2 and variants of concern","name":"articletitle","label":"Article Title"},{"value":"Current Research in Virological Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.crviro.2022.100019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100019"}}